Proton Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.98 Cr
- Revenue Growth %
- Profit Growth -89.89%
- Ebitda -12.41%
- Net Worth -12.73%
- Total Assets -9.78%
About Proton Pharma
Proton Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 2012 and has a history of 12 years and eight months. Its registered office is in Chandigarh, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.10 M.
The company has closed loans amounting to ₹1.98 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sumit Kumar, Sumit Tandon, and Ashwani Bhalla serve as directors at the Company.
Company Details
-
LocationChandigarh, Chandigarh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232CH2012PTC033816
-
Company No.
033816
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 May 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Proton Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Kumar
|
Director | 01-Nov-2019 | Current |
|
Sumit Tandon
|
Whole-Time Director | 18-Nov-2015 | Current |
|
Ashwani Bhalla
|
Director | 22-May-2012 | Current |
Financial Performance of Proton Pharma.
Proton Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 89.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proton Pharma?
In 2023, Proton Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dcm Pharma Private LimitedSumit Kumar is a mutual person
-
Drbest Pharmaceuticals Private LimitedAshwani Bhalla is a mutual person
-
Wagnerhuber Pharmaceuticals Private LimitedSumit Kumar and Ashwani Bhalla are mutual person
-
Alvizia Healthcare Private LimitedSumit Kumar is a mutual person
-
D M Pharma Private LimitedSumit Kumar is a mutual person
-
Vsaar Pharma Private LimitedSumit Kumar is a mutual person
Charges (Loans)
₹0
₹19.78 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2013 | Axis Bank Limited | ₹1.98 Cr | Satisfied |
How Many Employees Work at Proton Pharma?
Unlock and access historical data on people associated with Proton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
